Selected Publications
Naik S, Li Y, Talleur AC, Selukar S, Ashcraft E, Cheng C, Madden RM, Mamcarz E, Qudeimat A, Sharma A, Srinivasan A, Suliman AY, Epperly R, Obeng EA, Velasquez MP, Langfitt D, Schell S, Métais JY, Arnold PY, Hijano DR, Maron G, Merchant TE, Akel S, Leung W, Gottschalk S, Triplett BM. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: A phase II trial. J Hematol Oncol Jun 27;17(1):50, 2024.
Epperly R, Li Y, Selukar S, Zeng E, Madden R, Mamcarz E, Naik S, Qudeimat A, Sharma A, Talleur A, Dallas MH, Gottschalk S, Srinivasan A, Triplett B. Disease status and interval between hematopoietic cell transplantations predict outcome of pediatric patients who undergo subsequent transplantation for relapsed hematologic malignancy. Transplant Cell Ther May 1;30(5):526.e1-526.e11, 2024.
Aguilera V, Schaefer MR, Parris K, Long A, Triplett B, Phipps S. Psychosocial Outcomes of Parents in Pediatric Haploidentical Transplant: Parental Hematopoietic Cell Donation as a Double-Edged Sword. Bone Marrow Transplantation Epub 2022, Jan 10. doi: 10.1038/s41409-021-01547-9
Sharma A, Li Y, Huang S, Talleur AC, Suliman A, Qudeimat A, Srinivasan A, Mamcarz E, Madden R, Cheng C, Gottschalk S, Triplett BM. Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS. Bone Marrow Transplant Aug 1;56(8):1866-1875, 2021.
Mamcarz E, Madden R, Qudeimat A, Srinivasan A, Talleur A, Sharma A, Suliman A, Maron G, Sunkara A, Kang G, Leung W, Gottschalk S, Triplett BM. Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution. Bone Marrow Transplantation May;55(5):929-938, 2020. doi: 10.1038/s41409-019-0750-7. Epub 2019 Nov 18. PubMed PMID: 31740766; PubMed Central PMCID: PMC7202974
Sharma A, Kang G, Sunkara A, Inaba H, Jeha S, Cross SJ, Geiger T, Triplett B. Haploidentical Donor Transplantation Using a Novel Clofarabine-Containing Conditioning Regimen for Very High-Risk Hematologic Malignant Neoplasms. Journal Pediatric Hematology Oncology 40:e479-e485, 2018. PMID:29750747. DOI: 10.1097/MPH.0000000000001222
Triplett BM, Muller B, Kang G, Li Y, Cross SJ, Moen J, Cunningham L, Janssen W, Mamcarz E, Shook DR, Srinivasan A, Choi JK, Hayden RT, Leung W. Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared to CD3-targeted T-cell depletion. Transplant Infectious Disease Feb;20(1), 2018. PMID: 29178554. DOI: 10.1111/tid.12823
Triplett BM, Shook DR, Eldridge P, Li Y, Kang G, Dallas M, Hartford C, Srinivasan S, Chan WK, Suwannasaen D, Inaba H, Merchant TE, Pui CH, Leung W. Early Immune Reconstitution Recapitulating CD45RA-depleted Haploidentical Graft Content in Patients with Hematologic Malignancies. Bone Marrow Transplantation 50(7):968-977, 2015. PubMed PMID: 25665048; DOI: 10.1038/bmt.2014.324
Triplett B, Handgretinger R, Pui CH, Leung W. KIR-incompatible hematopoietic-cell transplantation for poor prognosis infant acute lymphoblastic leukemia. Blood 107(3):1238-9, 2006. PubMed PMID: 19212329, DOI: 10.1038/leu.2009.21
Last update: November 2024